Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction

Int J Dermatol. 2009 Dec;48(12):1338-42. doi: 10.1111/j.1365-4632.2009.04197.x.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Disease Progression
  • Doxorubicin / therapeutic use
  • Epstein-Barr Virus Infections / complications
  • Fatal Outcome
  • Female
  • Humans
  • Immunohistochemistry
  • Lymphohistiocytosis, Hemophagocytic / complications
  • Lymphoma, T-Cell, Cutaneous / complications
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Lymphoma, T-Cell, Cutaneous / immunology
  • Lymphoma, T-Cell, Cutaneous / metabolism
  • Lymphoma, T-Cell, Cutaneous / pathology*
  • Middle Aged
  • Natural Killer T-Cells / immunology
  • Nose Neoplasms / pathology*
  • Prednisone / therapeutic use
  • Skin Neoplasms / pathology*
  • Vincristine / therapeutic use

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol